Eun Ha Cho

Title: Innovations in Prostate Cancer Treatment by Eun Ha Cho

Introduction

Eun Ha Cho is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of prostate cancer. Her innovative work focuses on developing novel compounds that can effectively target tumor cells.

Latest Patents

Eun Ha Cho holds a patent for "GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer." This patent describes a groundbreaking compound that utilizes a radioisotope to label bombesin derivatives. These derivatives are capable of selectively targeting materials that are over-expressed in tumor cells, thereby enhancing the effectiveness of diagnosis and treatment methods for diseases associated with prostate cancer. She has 1 patent to her name.

Career Highlights

Eun Ha Cho is affiliated with the Korea Atomic Energy Research Institute, where she conducts her research. Her work is pivotal in advancing the understanding and treatment of prostate cancer, contributing to the development of more effective therapeutic strategies.

Collaborations

Eun Ha Cho collaborates with esteemed colleagues, including Jae Cheong Lim and Jin Joo Kim. These partnerships enhance the research efforts and broaden the impact of her innovations in the medical field.

Conclusion

Eun Ha Cho's contributions to prostate cancer treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work not only provides new avenues for diagnosis and treatment but also highlights the importance of collaboration in research.